*.*.*.
The New York Times

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Posted on by INTELLINEWS


Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.




Source
Exit mobile version

..........................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....